Clinical trial

Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn

NCT03007381

Study summary

ClinicalTrials.gov

Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Ketorolac Tromethamine Normalized identity: ketorolac tromethamine View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Normal Saline Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2017-11-01

PhasePHASE4

Conditions

Breast Cancer Femaleunresolved

Interventions

Ketorolac TromethamineDRUG · verified · RxNorm: ketorolac tromethamine

Normal SalineDRUG

Sponsors & collaborators

Nova Scotia Health Authoritylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03007381 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.